3 dimensional (3D) cardiac imaging refers to technique wherein two dimensional images are given the illusion of depth thereby giving an image a third dimension. 3D cardiac imaging has unleashed a great potential in diagnostics and surgery. The 3D cardiac imaging has resulted in improved understanding of the complex spatial arrangement of heart with the vascular system. Cardiovascular diseases (CVD) are one of the most common diseases worldwide. Various CVDs are abnormal heart rhythms, or arrhythmias, congenital heart disease, marfan syndrome, coronary artery disease, deep vein thrombosis causing pulmonary embolism, and cardiomyopathy.
COVID-19 has affected some sectors of healthcare industry deleteriously. The disruptions in supply chain and manufacturing, delayed procurement of medical devices combined with persion of public funds will have long-lasting impact on the 3D cardiac imaging market.
3D Cardiac Imaging Market: Drivers and Restraints
The growing prevalence of diabetes, smoking and obesity related complications result in heart conditions. This is expected to drive the growth of the 3D cardiac imaging market. Increasing number heart surgeries with prerequisite of cardiovascular imaging will further promote the 3D cardiac imaging market. Steadily growing geriatric population in countries like the USA, Japan, Canada, etc who are more prone to CVDs will further supplement the list of drivers for the 3D cardiac imaging market. Serious increases in LDL-cholesterol in many developing populations of the world will be a drive in the new emergent 3D cardiac imaging markets. The non-invasive nature of the 3D cardiac imaging results in more acceptability among the patients and lesser hospitalization rates. Greater the acceptability among stakeholders, greater is the growth of the 3D cardiac imaging market. Lastly, the low cost factor of the technique will also boost the market for 3D cardiac imaging. Regulatory regimes for tobacco coupled with various awareness drives by the government in countries like India will result in low incidences of heart conditions. This in effect can hinder the market growth for 3D cardiac imaging.
3D Cardiac Imaging Market: Segmentation
The global 3D cardiac imaging market is segmented based on the product type, clinical application type, end user type and region.
By product type, the global 3D cardiac imaging market is segmented as:
By clinical application type, the global 3D cardiac imaging market is segmented as:
By end user type, the global 3D cardiac imaging market is segmented as:
3D Cardiac Imaging Market: Overview
The global 3D cardiac imaging market is set to register robust growth owing to the increased incidences of heart complications. It has been reported that the number of people affected by CVDs will increase from 169 million in 2020 to 187 million in 2030. By product type, the portable handheld type has the potential to grow fastest in global 3D cardiac imaging market because of the convenience it provides. In the clinical application segmentation, diagnostics of CVDs is expected to grow steadily in global 3D cardiac imaging market.
3D Cardiac Imaging Market: Region-wise Outlook
North America will continue to dominate the global 3D cardiac imaging market owing high prevalence of heart related conditions. 50% of adult population of the USA is said be affected by one or the other heart condition. Heart disease is number one and stroke number 5th cause of death in the USA. Europe would be second in lead to drive the global 3D cardiac imaging market owing to its increasing geriatric population. More than half of all the deaths in the European region is due to cardiovascular disorders. South Asia and East Asia are believed to be the fastest growing regions in the global 3D cardiac imaging owing to increase of diabetic burden especially in countries like India. Africa will also be contributing substantially to the global 3D cardiac imaging market pertaining to its growing population.
3D Cardiac Imaging Market: Key Players
The key players in the 3D cardiac imaging market are Philips, GE Healthcare, Pie Medical Imaging, Siemens Healthineers, HeartSciences, Medis Medical Imaging, Shimadzu, Circle Cardiovascular Imaging, CardioComm Solutions Inc., TomTec, and Toshiba.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
Regional analysis includes:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.